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Abstract 
ZnO nanoparticles (NPs) are prone to dissolution and uncertainty remains whether 
biological/cellular responses to ZnO NPs are solely due to the release of Zn2+ or whether the 
NPs themselves have additional toxic effects. We address this by establishing ZnO NP 
VROXELOLW\ LQ GLVSHUVLRQ PHGLD 'XOEHFFR¶V 0RGLILHG (DJOH 0HGLXP '0(0 KHOG XQGHU
identical conditions to those employed for cell culture (37 oC, 5% CO2 and pH 7.68) and by 
systematic comparison of cell-NP interaction for three different ZnO NP preparations. For 
NPs at concentrations up to 5.5 Pg ZnO/mL, dissolution is complete (with the majority of the 
soluble zinc complexed to dissolved ligands in the medium), taking ca. one hour for uncoated 
and ca. 6 hours for polymer coated ones. Above 5.5 Pg/mL results are consistent with the 
formation of zinc carbonate, keeping the solubilised zinc fixed to 67 PM of which only 0.45 
PM is as free Zn2+, i.e., not complexed to dissolved ligands. At these relatively high 
concentrations, NPs with an aliphatic polyether-coating show slower dissolution (i.e. slower 
free Zn2+ release) and re-precipitation kinetics compared to uncoated NPs, requiring more 
than 48 hours to reach thermodynamic equilibrium. Cytotoxicity (MTT) and DNA damage 
(Comet) assay dose response curves for three epithelial cell lines suggest that dissolution and 
re-precipitation dominate for uncoated ZnO NPs. Transmission electron microscopy 
combined with monitoring of intracellular Zn2+ concentrations and ZnO-NP interactions with 
model lipid membranes indicate that an aliphatic polyether-coat on ZnO NPs increases 
cellular uptake, enhancing toxicity by enabling intracellular dissolution and release of Zn2+. 
Similarly, we demonstrate that needle-like NP morphologies enhance toxicity by apparently 
frustrating cellular uptake. To limit toxicity, ZnO NPs with non-acicular morphologies and 
coatings that only weakly interact with cellular membranes are recommended. 
 
CAS section: Toxicology 
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Introduction 
The widespread use of nanoparticles (NPs) in industry and consumer products has led to an 
intense research effort into the effects of engineered NPs on human health and the 
environment. Zinc oxide (ZnO) NPs are one of the materials that have been extensively 
studied because of their use in cosmetic preparations, especially in sun cream. Recent 
research has demonstrated that ZnO is likely to dissolve and undergo phase transformations 
in aqueous environments, typically forming nanoparticulate compounds of lower solubility 
(zinc-phosphates, -carbonates, -sulphides and/or -iron hydroxides).1-3 Dissolution of ZnO NPs 
and the re-precipitation as zinc carbonates and phosphates in different cell culture media has 
also been suggested; with the phosphate concentration of the media having a major effect on 
the equilibrium Zn2+ levels in solution.4, 5 As such, a careful assessment of the effect of 
solution chemistry on the physico-chemical properties of ZnO should be carried out as part of 
any complete nanotoxicology study.  
 
Since ZnO NPs are prone to dissolution,2, 6, 7 it has been suggested that the released free Zn2+ 
ions are responsible for the observed toxicity, including damage to DNA via the generation of 
radical oxygen species (ROS).8-10 For instance, Song et al. showed that the concentration of 
soluble zinc in the supernatant of a complete cell medium (Roswell Park Memorial Institute, 
RPMI 1640 medium supplemented with 10% fetal serum albumin) after centrifugation was 
about 10 Pg/mL.9 They suggested that this zinc fraction is the Zn2+ released by dissolution of 
ZnO NPs and assert that the dissolved Zn2+ contributed to about 50% of the observed cell 
death in vitro, where ROS levels in the cell were proposed to be mainly due to a cytotoxic 
response to Zn2+ inside the cell. The difference in toxicity between different ZnO particles 
was attributed to the non-dissolved particles.9 Other reports, however, suggest that ROS are 
generated at the surface of ZnO NPs (e.g., 11) or that ZnO NPs are directly taken up by cells, 
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increasing the intracellular Zn2+ concentration to toxic levels not achieved by extra cellular 
exposure to similar concentration of soluble zinc salts.12-14 This latter effect is supported by a 
report that direct NP-cell contact is required to generate toxicity within human cancer cells.15  
 
Also studies in vivo have started to address the role of ZnO dissolution. Cho et al. show that 
intratracheal instillation of ZnO NPs into the lungs of rats results in rapid pH-dependent 
dissolution of the ZnO in phagosomes and a toxic response consistent with the release of 
Zn2+.16 Sharma et al. fed mice 300 mg ZnO/kg for 14 consecutive days and detected an 
accumulation of Zn2+ in the liver, which was associated with significant oxidative stress.17 
 
To fully determine toxicity of NPs, it is now well established that in vitro toxicity assays need 
adjustments and that detailed physico-chemical characterisation of the NPs is required to 
cross-reference results for different sources of NPs.18-23 Ultimately, the toxicity of engineered 
NPs in general is dependent on the morphology, size (including hydrodynamic agglomeration 
state) and coating of the particles.19 For ZnO NPs, the additional dissolution kinetics are also 
likely to depend on the morphology, size, hydrodynamic agglomeration and coating of the 
particles as well as the composition and conditions of the medium the particles are suspended 
in. As such, it is possible that much of the uncertainty described above regarding the 
mechanism of ZnO NP toxicity is due to variation in dissolution kinetics.  
 
After an initial cell cytotoxicity screen of six different Zn NPs (Supplementary Information, 
Figure S1, Table S1) we have undertaken a systematic study of three different ZnO NP types 
(polymer coated, uncoated equiaxed and needle-like ZnO NPs). Here, we report on the 
equilibrium dissolution, dissolution rates and re-precipitation of these ZnO NPs in CO2 
buffered cell culture media and go on to compare the cytotoxicity and DNA damage to 
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investigate the role of released, free Zn2+.  We also investigate cellular uptake and interaction 
with lipid membranes to highlight the role of the less rapidly dissolved NP fraction. The 
results identify three mechanisms by which ZnO NPs can cause cytotoxicity.  
 
Experimental Procedures 
ZnO nanoparticles and characterisation 
NP sample 1, EZ-1; commercial, NanoTek® NPs were bought via Alfa Aesar (Cat #: 45409; 
the exact formulation and coating details were unreported). These ZnO NPs have a coating in 
order to disperse well in liquids; ATR-FTIR indicates the coating to be an aliphatic polyether 
(Supplementary Information, Figure S2 and S3). NP sample 2, EZ-2; commercial, uncoated 
NPs were bought from Alfa Aesar (Cat #: 44533). NP sample 3, EZ-3; nano-needles were 
hydrothermally synthesized from ZnCl2 and Na2CO3 dissolved in distilled water (140°C for 
12 h). The final precipitates obtained were separated from the liquid phase and washed 6 
times with distilled water. 
 
Physico-chemical characterisation 
Transmission electron microscopy (TEM) was conducted on an FEI Tecnai F20 FEG-TEM 
operated at 200 kV and equipped with a Gatan Orius SC600A CCD camera and an Oxford 
Instruments 80mm X-Max SDD detector. ZnO NPs were prepared for TEM by placing a drop 
of the NPs suspended in alcohol onto a copper TEM grid coated with a holey carbon support 
film (Agar Scientific Ltd.) and allowed to air dry before examination in the TEM. 
 
Dynamic Light Scattering (DLS) and Zeta Potential measurements were performed using a 
Malvern Zetasizer Nano ZS in water and (serum-free) cell culture media. Each sample was 
analyzed 5 times with the average result presented.  Powder X-ray Diffraction (XRD) was 
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undertaken using a Bruker D8 powder X-ray diffractometer fitted with a Vantec detector and 
using a Cu-.ĮVRXUFHc,QGXFWLYHO\&RXSOHG3ODVPD-Mass Spectrometry (ICP-MS) 
was conducted using a Perkin Elmer Elan DRC-e ICP-MS following centrifugation (for 35 
min in an Eppendorf MiniSpin Plus, at 14,500 rpm) and extraction of the supernatant of NP 
containing solutions.  Fourier Transform-Infra Red (FT-IR) spectrometry was conducted on a 
Thermo Scientific iS10 FTIR spectrometer using an attenuated total reflection (ATR) 
accessory. 
 
Dissolution assay 
Dissolution behaviour of ZnO NPs was investigated using the electro-analytical technique 
Absence of Gradients and Nernstian Equilibrium Stripping (AGNES),7, 24 which does not 
require any prior separation of the dispersed and liquid phases. Stock NP samples were 
suspended in MilliQ water at 1 mg/mL (or for EZ-1 the as-received colloidal suspension in 
water at a nominal concentration of 400 mg/mL was used). These were sonicated (Branson 
3510E-MT Ultrasound bath, 100 W 42 KHz) for 10 min prior to dispersion at the appropriate 
concentrations in polarographic cells containing 'XOEHFFR¶V 0RGLILHG (DJOH 0HGLXP
(DMEM; Sigma, UK, cat D5796) held at 37.0 r 0.1 qC and in 5% CO2 (r 0.5%) for careful 
control of pH and temperature. DMEM is buffered with sodium bicarbonate (3.7 g 
NaHCO3/L), contains only a small amount of phosphate (0.109 g NaH2PO4/L) and pH is 
fixed at 7.68 r 0.04 throughout the experiment by inclusion of 5% CO2 in the environment. 
Dissolution studies were undertaken on EZ-1, EZ-2 and ZnO NPs purchased from Sigma-
Aldrich (cat no. 544906). No significant differences were observed between the two uncoated 
NPs (EZ-2 and Sigma-Aldrich). The latter NPs have been characterised previously7 and 
shown to be phase pure by XRD with a primary equiaxed particle morphology ~70 nm in 
diameter. When dispersed in water they coalesced to agglomerates with a hydrodynamic 
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diameter of ~140 nm and when dispersed in water plus a background electrolyte (at 0.1 ionic 
strength) they coalesced to agglomerates with a hydrodynamic diameter of ~1100 nm. 
 
Cell culture, viability and genotoxicity assays 
A549 (human lung alveolar carcinoma) cells and HT29 (human colon cancer) cells (Sigma-
Aldrich) were cultured in DMEM containing 10% foetal bovine serum (Lonza, Slough, UK) 
with 0.5% penicillin/streptomycin. HaCaT (human keratinocyte) cells (gifted from within the 
University of Leeds) were cultured in RPMI media (Gibco, Paisley, Scotland) containing 
10% foetal bovine serum (Lonza, Slough, UK) with 0.5% penicillin/streptomycin. All cell 
lines were incubated at 37q C in humidified 5% CO2 until they were approaching confluence, 
when they were harvested using trypsin-ethylenediamine tetra-acetic acid (EDTA) and then 
re-seeded. 
 
Effects of ZnO NPs on the viability and genetic fidelity of the cells were evaluated using the 
MTT (thiazolyl blue tetrazolium bromide) and Comet assays, respectively, using a modified 
protocol to that described previously.25 Suspensions of EZ-2 and EZ-3 were made in water (1 
mg/mL and 10 mg/mL) and bath-sonicated (Decon, FS minor) for 30 min before adding them 
to the cell media in appropriate concentrations. We note that in this assay the cells have been 
incubated with ZnO NPs for 24 h in the absence of foetal bovine serum. In the MTT assay, 
light absorption was corrected for dispersion from the ZnO NPs by using transmission 
intensities from wells containing no cells. For control studies with ZnSO4 (Sigma-Aldrich), 
the exposure concentrations were adjusted to give the same molar content of elemental Zn as 
the experiments with ZnO NPs.  Cell viability and DNA tails are expressed as percentage 
YLDELOLW\'1$WDLOFRPSDUHGZLWKXQWUHDWHGFRQWUROV6WXGHQW¶V t-test was used to determine 
significance (p<0.05).  
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Cytoplasmic Zn-ion concentration 
A549 cells were cultured on 35 mm glass-bottom culture dishes (World Precision 
Instruments) for live imaging. Cell growth medium was the same as mentioned previously. 
Prior to imaging, growth medium was removed from dishes, followed by rinsing once with 
warm imaging buffer (10 mM HEPES at pH 7.4 containing 134.3mM NaCl, 5 mM KCl, 1.2 
mM MgCl2, 1.5 mM CaCl2 and 1.44% glucose). 5 µM cell-permanent Zn2+ indicator, 
FluoZin3-AM (Invitrogen), was loaded at 37°C for 45 min. Warm imaging buffer was used 
twice to wash cells for 15 min at 37 °C each time, so as to remove any dye that was not 
specifically associated with the cells. ZnO suspensions in imaging buffer were made as 
described above for the viability and genotoxicity assays. Live imaging was started 
immediately after addition of ZnO NPs or ZnCl2 (Sigma-Aldrich) using a Delta Vision 
confocal microscope. A 488 nm wavelength laser was used to excite FluoZin3-AM (EX 494 
nm/EM 516 nm). Images were captured from five regions of interest over a period of ~6 h via 
a 20x objective and each experiment was conducted twice. Fluorescence at each time point 
was averaged after quantification ((F-F0)/F0) with ImageJ software, in which F is the 
fluorescence as a function of time and F0 at time zero, before addition of ZnO or ZnCl2.  
 
TEM sample preparation 
Cell preparation: the ZnO exposed cells (1000 Pg/ml; EZ-1 exposed for 1 h, EZ-3 exposed 
for 6 h) were harvested and placed in fixative (2% glutaraldehyde and 2% formaldehyde in 
100 mM PIPES buffer), washed in a buffer, then spun into pellets and fixed in 1% osmium 
tetroxide. Following dehydration by a series of ascending strength alcohols and washing with 
dry acetone, the specimens were infiltrated with TAAB resin which was polymerised at 60 oC 
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for 24 h. Sections were cut from the polymerised block with a nominal thickness of 90 nm 
using an ultra-microtome (Leica Ultra-cut E) and placed on a copper grid (Agar Scientific). 
Both stained (uranyl acetate and lead citrate) and unstained sections were examined by the 
TEM described previously.  
 
Model Membrane Assays 
Lipid vesicle leakage assays and quartz crystal microbalance measurements on solid-
supported bilayer systems were conducted as described previously,25 except that in this study 
a lipids mixture was used that represents the lipid composition of a typical eukaryotic plasma 
membrane, but without the sphingomyelin fraction (POPC:DOPE:DOPS:cholesterol in a 
9:6:1:4 weight ratio). 
 
Results 
Characterisation and dissolution 
A range of physico-chemical properties were characterised for all the ZnO NPs under study 
here (Table 1). TEM was used to determine size and morphology of the samples: for EZ-1 the 
average near equiaxed particle length is 30±20 nm with the coating not detectable by TEM 
but identifiable by FTIR as an aliphatic polyether (Supporting Information, Figure S1 and 
S2); for the uncoated near equiaxed EZ-2, the average particle length is 40±20 nm; and for 
EZ-3, the average nano-needle size is 1000±500 nm in length and 120±60 nm in width. 
Powder XRD was used to confirm crystallinity and to indicate (crystalline) phase purity; all 
samples exhibit the expected zincite phase. DLS measurements revealed NP agglomeration 
upon dispersion in water and cell culture media, with the uncoated NPs and nano-needles 
showing significant flocculation, while the polymer coated NPs remain well dispersed. The 
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zeta potential for the coated NPs when dispersed in water is negative (-14 mV), whereas for 
the uncoated samples and nano-needles it is positive (5 and 19 mV respectively).  
 
ICP-MS measurement of the soluble zinc supernatant of ZnO NP dispersions in water and 
cell culture media at NP concentrations of 100 Pg/mL (Table 1) indicate levels at the same 
order of magnitude to those first reported in water by Franklin et al.26 and in media by Song 
et al.9 We have previously shown that control of pH is absolutely essential, since a decrease 
of just 0.15 pH units implies a doubling of the free Zn2+ concentration of a solution 
containing non-dissolved ZnO NPs.7 It is important to note that for sodium bicarbonate 
buffered cell culture media, like DMEM, small changes in temperature and particularly CO2 
levels can lead to significant changes in solution pH. We have used the electroanalytical 
method AGNES in order to directly (i.e. without any prior separation steps) measure the free 
Zn2+ concentration produced by the dissolution of the ZnO NPs (EZ-1, EZ-2 and Sigma-
Aldrich NPs) when dispersed in DMEM cell culture medium at 37±0.1 oC and in 5% (±0.2%) 
CO2, so that solution pH is controlled to 7.68±0.04 (Figure 1).  Sequential additions of 
Zn(NO3)2 (Merck) to the DMEM results in a linear rise in Zn2+ measured in solution by 
AGNES (Figure 1). The free Zn2+ concentrations are two orders of magnitude lower than the 
added concentrations of Zn(NO3)2, indicating a huge complexation capacity of the ligands 
present in DMEM (amino acids, etc.) for Zn2+. Equilibrium chemical modelling (Visual 
MINTEQ Version 3.0), consistent with Preis and Gamsjäger,27 indicated that in DMEM, 
ZnCO3 (smithsonite) should precipitate when more than 4.5u10-7 M µIUHH¶ XQFRPSOH[HG, 
Zn2+ is present.  This equilibrium concentration in DMEM is ca. two orders of magnitude 
below that in equilibrium with bulk ZnO (zincite). However, further additions of Zn(NO3)2 
result in a continued rise of measured free Zn2+ in solution, indicating supersaturation (Figure 
1; note that one would expect an increase in gradient of the free Zn2+ curve if the key 
  12 
complexing ligands were depleted from the solution at this stage). Importantly, when ZnO 
NPs are added to the supersaturated solution, a decrease in free Zn2+ is observed, down to a 
value consistent with the concentration in thermodynamic equilibrium with ZnCO3, 
suggesting that precipitation occurs. A loose, white precipitate different in form to the solid 
ZnO NPs is indeed visible at this stage and we propose that this is due to the ZnO NPs 
providing nucleation sites for carbonate precipitation in the supersaturated solution. 
Additions of ZnO NPs to pristine DMEM solutions result in the formation of similar loose, 
white precipitates and measured values of free Zn2+ that are consistent with the solubility of 
ZnCO3 and not ZnO (Figure 1).  
 
It is noteworthy that the equilibrium solubility in DMEM estimated by AGNES (5.5 Pg 
ZnO/mL; Figure 1) is in good agreement with the values estimated by ICP-MS (5.1-6.5 Pg 
ZnO/mL; Table 1), despite concerns regarding the overestimation of Zn solubility by ICP-
MS.28 In addition, we have also measured dissolution kinetics by AGNES.  At concentrations 
above 5.5 Pg/mL ZnO, uncoated NPs (including EZ-2) typically reach the thermodynamic 
solubility limit in equilibrium with ZnCO3 within 3-6 h, whereas the coated ZnO NPs (EZ-1) 
approach this limit only after 48 h incubation (Figure 1, data points labelled with letters and 
Supplementary Information, Figure S4). In conclusion therefore, the addition of up to 5.5 
Pg/mL ZnO NPs (70 PM Zn) to DMEM leads to a relatively fast, full dissolution of ZnO 
NPs, with the majority of the liberated Zn2+ ions complexed to organic ligands in the media 
(only 0.45 P0 =Q LV µIUHH¶ LQ VROXWLRQ DV XQFRPSOH[HG =Q2+). It is not clear yet whether 
dispersions of ZnO NPs above this concentration dissolve entirely and re-precipitate as 
ZnCO3 or whether a ZnCO3 coating of the partially dissolved NPs would result in the 
retention of some ZnO.  Also, the formation of mixed phosphate/carbonate solid phases 
cannot be excluded from the available data. 
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Cyto- and genotoxicity 
Cytotoxicity of the ZnO NPs and a ZnSO4 solution was tested on two epithelial cell lines 
after a 24 h incubation period (Figure 2 and Additional File, Table S1). The concentration of 
ZnSO4 was adjusted to give the same Zn content as used in the assays with ZnO (i.e., ZnSO4 
was tested at the same Zn-molarity as ZnO). The cytotoxicity tests gave a wide range of 
responses, but some general observations can be made. First, the ZnO NPs are no more 
cytotoxic than the ZnSO4 control. Second, the uncoated, equiaxed NPs (EZ-2) always 
induced a lower response than the other particles and this NP type was the only one tested to 
yield median lethal concentration (LC50) values consistently higher than 100 Pg/mL for all 
cell types (Additional File, Table S1). In order to test if the composition of the culture 
medium had a significant effect, a third cell line was tested.  Although HaCaT epithelial cells 
are typically grown in DMEM media, we have cultured them in RPMI media, which is a 
more phosphate-rich culture medium than DMEM and could therefore result in re-
precipitation of the relatively insoluble, zinc phosphate hydrates, as suggested previously.4,5 
In all but one case, the HaCaT cells incubated in RPMI are more sensitive to ZnO NPs than 
ZnSO4 suggesting either the different intrinsic sensitivity of these cells compared to the 
previous model systems, or the different behaviour of zinc in the richer phosphate 
environment, specifically regarding its possible transformation into other secondary 
precipitates such as hopeite (Zn3(PO4)2:4H2O). 
 
 Based on the cytotoxicity results, the three cell lines were treated with ZnO NPs at 
FRQFHQWUDWLRQVXSWRȝJP/or 1 Pg/mL for HaCaT cells (significant cell death at higher 
concentrations hampers the interpretation of the assay results) to measure the induction of 
DNA damage using the Comet assay.29 The results show a small, but significant increase in 
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'1$GDPDJHFRPSDUHG WRFRQWUROVDWFRQFHQWUDWLRQVRIȝJP/ ZnO for HT29 cells for 
the polymer coated NPs (EZ-1) and the uncoated nano-needles (EZ-3; Figure 3). For the 
HaCaT cells, only the polymer coated NPs (EZ-1) show an increase in DNA damage at 1 
ȝJP/, while the A549 cells are not significantly affected by any of the NPs (Figure 3). 
 
EZ-2 seems to have a much lower cytotoxicity than EZ-1 or EZ-3 and the Comet assay 
results suggest this is not due to differences in DNA damage. To study further the mechanism 
of cytotoxicity, we measured the intracellular Zn2+ concentration in A549 cells upon addition 
of the three NP types. We note that this assay could not be done in DMEM, but is performed 
in an imaging buffer that does not contain carbonate or phosphate and does contain 1.5 mM 
CaCl2. As the imaging buffer is devoid of amino acids and other potential soluble Zn ligands, 
=Q2GLVVROXWLRQVKRXOGUHVXOWLQPXFKKLJKHUµIUHH¶=Q2+ in solution; equilibrium solubility of 
ZnO in the imaging buffer has been measured to be ~20 Pg/mL.7 Correspondingly, 
cytoplasmic Zn2+ concentrations in A549 cells incubated for up to 350 min with the three 
ZnO NPs at exposure doses of 20 Pg/mL do not show a clear rise or distinction between the 
NPs and a ZnCl2 solution, despite possible perturbation from the high Ca2+ concentration 
(Figure 4). At 1 mg/mL, however, the relative intracellular Zn2+ concentrations vary 
considerably. The uncoated NPs (EZ-2) and ZnCl2 solution both show a sharp rise between 
40 and 50 min and then decline by 40%. In contrast, both the polymer coated NPs (EZ-1) and 
nano-needles (EZ-3) exhibit an almost linear, steady rise of Zn2+ up to 350 min (Figure 4). 
This continuous rise in intracellular Zn2+ concentration for the polymer coated ZnO NPs (EZ-
1) and uncoated nano-needles (EZ-3) cannot solely be explained by the slower dissolution 
rates evidenced by AGNES (Figure 1), as the final intracellular Zn2+ concentration after 350 
min is significantly higher compared to cells incubated with ZnCl2. Instead, we suggest that 
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at very high NP exposures, EZ-1 and EZ-3 have additional affects due to direct interaction 
between non-solubilised NPs and the cells.  
 
TEM 
In order to determine whether the polymer coated NPs (EZ-1) and uncoated nano-needles 
(EZ-3) are taken up by cells and if they are, where they localise within the cell, TEM images 
were recorded for A549 cells incubated with 1 mg/mL ZnO under identical conditions to the 
viability assay. TEM of the cells incubated with the polymer coated NPs (EZ-1) for 1 h 
showed that the majority of cells were intact and that ZnO NPs (or possible ZnCO3 
particulates) were present in the cytoplasm, albeit partially dissolved (Figure 5). TEM of the 
cells incubated with nano-needles (EZ-3) for 6 h showed potentially non-viable cells with 
partially dissolved needles, incompletely internalised (Figure 6). 
 
Model Membrane Interaction 
At exposure doses of 1 mg/mL, temporal cytoplasmic Zn2+ concentrations suggest that the 
uncoated, equiaxed ZnO NPs (EZ-2) produce a similar response to ZnCl2 solutions, while the 
polymer coated NPs (EZ-1) and uncoated nano-needles (EZ-3) follow a different pathway 
(Figure 4). TEM confirms incomplete cellular internalization for these latter two particle 
types (Figures 5 and 6). In order to test if either response could be due to a strong interaction 
between the particles and the plasma membrane, the interaction of the NPs with model 
membranes was investigated.  
 
First, to study whether the ZnO NPs can cause membrane disruption, vesicle-leakage assays 
were performed in DMEM. 400-nm diameter unilamellar vesicles composed of 
POPC:DOPE:DOPS:cholesterol (9:6:1:4 weight ratio) were loaded with an auto-quenching 
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fluorescent dye and incubated with the NPs. Release of the dye from a vesicle results in a 
dilution of the fluorescent dye, raising the observed fluorescence intensity. Indeed, significant 
increases in fluorescence intensity were observed upon addition of all three NP types tested 
(EZ-1, 2 and 3), indicating some dye is released and the membrane integrity compromised 
(Figure 7a). Increasing the exposure dose of all three NP types increased the release of dye, 
however the polymer coated NPs (EZ-1) provoked the highest leakage at all doses and at 100 
Pg/ml compromised the majority of the vesicles (unlike the other two particle types that 
induced < 20% leakage at this ZnO dose). 
 
To explore the relatively enhanced ability of the polymer coated NPs (EZ-1) to provoke 
vesicle leakage, the ability of these particles to bind to a lipid membrane was studied with a 
Quartz Crystal Microbalance with Dissipation (QCM-D). A tethered bilayer lipid membrane 
composed of POPC:DOPE:DOPS:cholesterol (9:6:1:4 weight ratio) is formed on silicon-
oxide coated QCM-D crystal. After exchanging the buffer for DMEM, binding of NPs on top 
of the planar lipid membrane was monitored with QCM-D. 8SRQ DGGLWLRQ RI  ȝJP/
polymer coated NPs (EZ-1), a slight decrease in QCM-D frequency was observed indicating 
binding to the membrane (Figure 7b). At the same time, the dissipation of the oscillation rose 
by very little, indicative of a tight interaction between the rigid NPs and the lipid membrane. 
A larger decrease in frequency and a corresponding small rise in dissipation are observed 
with the addition of 100 Pg/mL. A smaller response is evident for the subsequent addition of 
1 mg/mL, suggesting complete coverage of the membrane has been achieved between the two 
exposure doses. Finally, rinsing the system did not significantly change the frequency or 
dissipation, suggesting that most of the polymer coated NPs are not released from the 
membrane and the NPs are bound irreversibly (Figure 7b). Much less binding was observed 
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for EZ-2 and EZ-3 and all binding was reversible (not shown), suggesting that the coating of 
EZ-1 enhances interaction with the model membranes and possibly with plasma membranes. 
 
Discussion 
,WLVUHFRJQLVHGWKDWPXFKRIWKHWR[LFLW\RI=Q213VLVGXHWRWKHFRPSRXQG¶VVROXELOLW\DQG
the release of Zn2+ into solution. It is still not clear however, whether observed increases of 
intracellular Zn2+ result from NP dissolution following dispersion in physiological media 
typically used to culture cells or from cellular uptake of the NPs with subsequent intracellular 
dissolution and release of Zn2+ (for a review see, for instance, Vandebriel and de Jong10). We 
have used well-characterised ZnO NPs (Table 1) to resolve this uncertainty and we conclude 
that toxic pathways depend on the equilibrium solubility of the ZnO in the dispersion media 
plus, at relatively high concentrations or short incubation times, the surface coating and 
morphology of the NPs.  We note that our analysis excludes the presence of serum proteins 
because these are known to interact with ZnO nanoparticles, enhancing membrane activity30 
yet the impact of serum concentration on the amount of cellular uptake and the biological 
response to the exposure, is not fully understood (see for example23).  
 
Up to 5.5 Pg/mL of ZnO (70 PM Zn), the particles fully dissolve in DMEM (albeit at a 
slower rate if polymer coated), while above this concentration, insoluble ZnCO3 (smithsonite) 
is most likely formed (Figure 1). This stable equilibrium applies to appropriately buffered cell 
culture media and is in broad agreement with previous work on less well buffered systems. 
Reed et al. used chemical equilibrium modelling to predict the likely re-precipitation of less-
soluble zinc hydrocarbonate (hydrozincite) in moderately hard water and zinc phosphate 
hydrate (hopeite) in the phosphate-rich RPMI cell culture medium.4 They verified and 
quantified the formation of re-precipitated particulates in solutions containing EZ-1 amongst 
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several ZnO NPs tested (as did Turney et al for soluble zinc salts in RPMI5). Reed et al. also 
measured the polymer coated ZnO NP (EZ-1) solubility in DMEM (supplemented with 
bovine serum albumin) and observed similar Zn2+ levels in solution to those reported here. 
However, the pH of their DMEM containing EZ-1 dropped over time and correspondingly, 
the levels of soluble Zn rose. Such a change in pH would not occur for a cell line buffered in 
DMEM at 37 oC and in 5% CO2 and it is under these conditions that we show a stable 
equilibrium solubility level equivalent to the complete dissolution of 5.5 Pg/mL of ZnO, 
releasing 67 PM Zn2+ of which only 0.45 PM is not complexed to organic ligands and 
remains free in solution. For DMEM with ZnO concentrations above 5.5 Pg/mL, we have not 
established if the solid fraction of Zn is re-precipitated zinc carbonate (and/or phosphate) 
particulates, or whether some ZnO NPs are retained with a carbonate coating. Regardless, 
above the zinc carbonate equilibrium concentration, phase transformed, lower solubility 
particles will be retained during cellular exposure, consistent with previous observations.4, 5 
 
We show that, uncoated, equiaxed ZnO NPs (EZ-2) induce a drop in cell viability at 
concentrations well above those of ZnSO4 solutions in three different epithelial cell lines 
(Figure 2 and Supporting Information, Table S1). The higher cytotoxic response of ZnSO4 
compared to EZ-2 could be because additions of ZnSO4 can lead to supersaturation of Zn2+ 
with respect to the zinc carbonate equilibrium solubility of DMEM, as has been observed in 
our solubility experiments (Figure 1). This would imply that the zinc carbonate particulates 
are less cytotoxic than dissolved Zn2+. Also the polymer coated ZnO NPs and uncoated nano-
needles (EZ-1 and 3, respectively) do not exhibit a more acute cytotoxicity than that of 
ZnSO4 (Figure 2). However, they do provoke a significantly stronger response than EZ-2, 
suggesting that the coating and the morphology affect cytotoxicity. EZ-1 and EZ-3 are able to 
induce a steady rise in intracellular Zn2+ to concentrations above that of EZ-2 or ZnSO4 
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(Figure 4). TEM confirms the cellular uptake of partially dissolved, polymer coated ZnO NPs 
and uncoated nano-needles (Figures 5 and 6, respectively). The nano-needles (EZ-3) readily 
flocculate upon dispersion in cell culture media (Table 1) such that sedimentation and rapid 
contact with cell membranes will occur during exposure but even so, they are incompletely 
internalised (Figure 6). We suggest that this incomplete or frustrated cellular uptake 
contributes to the acute cell viability response (Figure 2); uptake of ZnO nano-needles has 
been shown in human macrophage monocyte cells13 but A549 cells are not normally 
phagocytic and may struggle to complete endocytic internalisation of such large needle 
agglomerates (Table 1). Frustrated cellular uptake is an established phenomenon for fibres in 
general.31 Endocytic cellular uptake of the polymer coated ZnO NPs (EZ-1) however, does 
not appear to be frustrated (Figure 5) and is consistent with the slower dissolution rate of 
these NPs (Figure 1 and Figure S4). Additional experiments with model membranes confirm 
that EZ-1 binds to lipid membranes, possibly promoting endocytic uptake and raising 
intracellular Zn2+ (Figure 7). Alternatively, our vesicle leakage assay shows that EZ-1 has a 
disrupting effect on the membrane, thus it cannot be excluded that EZ-1 compromises the 
plasma membrane, thereby allowing ZnO and Zn2+ to passively enter the cell. It is currently 
not clear whether the aliphatic polyether polymer coat of EZ-1 is responsible for disrupting 
the lipid or whether a stable colloid suspension of ZnO is more damaging than agglomerates 
of ZnO/ZnCO3 NPs. It has been shown recently however that the lipid membrane activity of 
ZnO NPs is enhanced in the presence of serum albumin because it forms a protein corona 
around the NPs.30 It could be that the protein corona and aliphatic polyether polymer coating 
of EZ-1 have a common physical mechanism by which they impair the integrity of a lipid 
membrane. 
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Ultimately, it may be that exposing ZnO NPs to CO2 rich atmospheres during the 
manufacture of ZnO NP products, to develop a ZnCO3 coating, could mitigate much of the 
toxicity reported thus far. Obviously, any coating would have to not interfere significantly 
with the original performance properties of the NPs. 
 
Conclusions 
Overall, our data indicate the importance of understanding the role of the content of cell 
culture media used for testing the toxicity of ZnO NPs to cell lines in vitro. Cell viability (and 
induced DNA damage) depends on the equilibrium solubility of ZnO in the culture media 
(5.5 Pg/mL ZnO or 67 PM Zn for dispersions in DMEM, held at pH 7.68). At NP 
concentrations well above the equilibrium solubility limit, ZnO NP morphology and surface 
coating are also factors. Polymer coatings that slow dissolution but promote strong 
interaction with lipid membranes will enhance the toxicity of ZnO NPs through increased 
cellular uptake followed by intracellular dissolution. In order to limit toxicity, surface 
coatings that prevent dissolution in these media, maintain NP dispersion and do not enhance 
interactions with cellular membranes should be sought. Similarly, needle-like morphologies 
also enhance the toxicity of ZnO NPs at high concentrations, by apparently frustrating 
cellular uptake. Thus, ZnO NP synthesis that avoids producing acicular morphologies is 
recommended.  
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Table 1: Physico-chemical properties of the three ZnO NPs 
 EZ-1 EZ-2 EZ-3 
Name Aliphatic Polyether 
Coated
a
 NPs 
Uncoated NPs Uncoated Nano-needles 
Source Alpha Aesar 45409 Alpha Aesar 44533 In-house 
TEM 
   
Particle size 
b
L = 30 ± 20 nm 
W = 16 ± 10 nm 
FR = 1.9 ± 0.8 
b
L = 40 ± 20 nm 
W = 30 ± 12 nm 
FR = 1.5 ± 0.3 
c
L = 1024 ± 496 nm 
W = 115 ± 59 nm 
FR = 9.8 ± 4.4 
XRD Consistent with zincite (01-071-6424) = hexagonal phase 
Hydrodynamic 
diameter 
water
d 
70-150 nm 
Stable 
90-160 nm 
390-670 nm  
Unstable 
250-540 nm 
2520-3030 nm 
Unstable 
Hydrodynamic 
diameter 
media
d 
40-140 nm 
Stable 
1330-2150 nm 
Unstable 
e
180-1590 nm 
2520-3050nm 
Very unstable 
Zeta potential
f 
-14 ± 6 mV 5 ± 5 mV 19 ± 5 mV 
Dissolved ZnO 
in water by 
ICP-MS 
g
  
1.73 r 0.03 Pg/mL 
 
1.19 r 0.03 Pg/mL 
 
NA 
Dissolved ZnO 
in medium by 
ICP-MS 
g
  
6.5 r 0.2 Pg/mL 
 
5.1 r 0.1 Pg/mL 
 
h
16.5 Pg/mL 
Dissolved ZnO 
in medium by 
AGNES 
5.5r 0.7 iPg/mL 5.5r0.7iPg/mL NA 
a
Coating type is unreported by manufacturer however FTIR indicates it to be an aliphatic polyether. 
Primary particle size measured from 
b
250 particles and 
c
109 nano-needles in TEM images (FR = Feret 
ratio).  
d
Hydrodynamic diameters measured in water at 25 
o
C at 1000 Pg/mL and in media at 37 oC 
and 100 Pg/mL, except e measured at 37 oC and 1000 Pg/mL. fZeta potential measured in water, with 
errors from FWHM. 
g
ICP-MS conducted on supernatants from ZnO dispersions in DMEM at 37 
o
C and 
100 Pg/mL. hin RPMI, iat 95% confidence level, estimated from AGNES measurements and free Zn2+ 
concentration expected in equilibrium with ZnCO3. 
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Figure Legends 
Figure 1: Free Zn2+ concentration after addition of Zn(II) salt solutions or ZnO NPs to 
DMEM at 37.0 ºC under 5% CO2/ 95% N2 atmosphere with pH = 7.68. Markers: Zn(NO3)2 
(plus signs); uncoated Sigma-Aldrich ZnO (open circles); uncoated EZ-2 particles 
(diamonds); coated EZ-1 particles (filled circles). The letter by the markers denotes the 
incubation time in DMEM: a) 30 min; b) 2 h; c) 18-24 h; d) 48 h. The values measured with 
Zn(NO3)2 (plus signs) remained constant for at least 6 h. The red and blue dashed lines 
denote the free Zn2+ concentration in equilibrium with solid ZnCO3 (smithsonite) and ZnO 
(zincite) bulk phases, respectively, as calculated with Visual MINTEQ (Version 3.0). Note 
the logarithmic scale of all axes, where concentration units are expressed in mol/L (left and 
bottom) and its equivalence in Pg ZnO/mL (right and top). The zinc carbonate equilibrium 
solubility level is equivalent to the complete dissolution of 5.5 Pg/mL of ZnO in this medium. 
 
Figure 2: Viability of A549, HT29 and HaCaT cells after 24 h incubation with a range of 
concentrations of ZnO nanoparticle types, EZ-1, -2 and -3 as indicated. Responses to ZnSO4 
solutions are also included. Asterisks indicate significance with * for p<0.05; ** for p<0.01 
and *** for p<0.001. 
 
Figure 3: DNA strand breaks in A549, HT29 and HaCaT cells following 24 h incubation 
with a range of concentrations of the three ZnO NP types as determined by the Comet assay 
(the 0.1 Pg/mL concentration of EZ-2 was not tested). Asterisks indicate significance with * 
for p<0.05; ** for p<0.01 and *** for p<0.001. 
 
Figure 4: Cytoplasmic Zn concentration of A549 cells as a function of time after addition of 
the three different ZnO NP types and ZnCl2 at a concentration of either 20 Pg/mL (open 
symbols) or 1 mg/mL (closed symbols). Zn concentration was measured with the fluorescent 
dye FluoZin3-AM and fluorescence intensity is given as (F ± F0)/(F0), where F0 is the 
intensity at time zero and F the intensity at the indicated time.  Error bars indicate the range 
(standard deviations) of fluorescence measurements at each time point. 
 
Figure 5:  A: TEM images of an A549 cell after 1 h incubation at 37ºC with 1 mg/mL of the 
polymer coated NPs (EZ-1); section is not stained with heavy metals. B: An enlargement of 
the dashed square shown in image (A). C: Enlargement of the dashed square in (B) showing 
  27 
ZnO NPs encapsulated within the cytoplasm (note the porous, partially dissolved morphology 
of the NPs). D: EDX spectrum of the area in image (C) confirming the ZnO composition 
(above background) of the NPs (Os decorates lipid membranes following fixation and the Cu 
background is generated by the TEM support grid).  
 
Figure 6:  A: TEM images of two A549 cells after 6 h incubation at 37ºC with 1 mg/mL of 
nano-needles (EZ-3); section is stained with heavy metals (U and Pb) for image contrast. B 
and C: Enlargements of the dashed squares shown in image, with the regions of intact 
membrane marked in red (A). Note the incomplete internalization of the needles and their 
porous, partially dissolved morphology.  D: EDX spectrum of the area in image (C) 
confirming the ZnO composition (above background) of the needle relics (with additional 
signals from the heavy metal stains).  
 
Figure 7: A: Leakage of carboxyfluorescein (CF) from CF-loaded (50 mM) vesicles in 
DMEM after the addition of 1, 1DQGȝJP/RI WKH WKUHH=Q213VDV LQGLFDWHG. 
Leakage was determined from the fluorescence intensity of CF with 0% leakage taken as the 
fluorescence prior to addition of ZnO NPs and 100% leakage is defined as the fluorescence 
measure after addition of 1% Triton X-100. The vesicles (~ 400 nm) are made up from 
POPC:DOPE:DOPS:cholesterol (9:6:1:4 weight ratio). B: Adsorption of the polymer coated 
NPs (EZ-1) on to a solid-supported bilayer lipid membrane (sBLM) as measured with quartz-
crystal microbalance with dissipation (frequency ± bottom; dissipation ± top). The formation 
of the sBLM (between 0 and 50 min) from vesicles containing 
POPC:DOPE:DOPS:cholesterol (9:6:1:4 weight ratio) is not shown for clarity. Arrows 
indicate additions to the DMEM stock solution of increasing concentrations of NPs, followed 
by a final rinse with DMEM. 
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